J Scott Daniels

Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).

Peter Chase, P Jeffrey Conn, Craig W Lindsley, 2013, Journal of medicinal chemistry.

Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats.

Po-Chang Chiang, David R. Anderson, Steve P. Wene, 2009, Journal of pharmaceutical sciences.

Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener.

Haibo Yu, Meng Wu, Craig W Lindsley, 2011, ACS chemical neuroscience.

Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.

Thomas Wichmann, Jocelyne Bachevalier, Adriana Galvan, 2017, ACS chemical neuroscience.

Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells.

Craig W Lindsley, Paul G Thomas, Sarah A. Scott, 2013, Journal of medicinal chemistry.

Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring

Eric Vogan, Jeffrey J. Sutherland, T. Daly, 2017, PloS one.